CTOs on the Move

MD Revolution

www.mdrevolution.com

 
MD Revolution harnesses the power of digital health technology to predict, prevent, and reverse chronic disease – and lower healthcare costs. MD Revolution is a transformational digital health provider that delivers a proven population health management service. Our SaaS solution, RevUp, has revolutionized the approach to behavior change for lifestyle diseases including diabetes, obesity, and heart disease. Participants on RevUp receive actionable feedback based on personal health data gathered from wearables and apps. Predictive analytics drive real-time identification of individuals that will or will not achieve desired health outcomes, thereby allowing clinicians and health coaches to focus on participants who require more ...
  • Number of Employees: 250-1000
  • Annual Revenue: $0-1 Million
  • www.mdrevolution.com
  • 9191 Towne Centre Drive, Suite 510
    San Diego, CA USA 92122
  • Phone: 858.847.5064

Executives

Name Title Contact Details

Funding

MD Revolution raised $23M on 12/07/2015

Similar Companies

Broadlane

The Broadlane Group is a leading end-to-end cost management partner for healthcare providers, with product offerings grouped into six service lines that allow healthcare providers to maximize cost efficiencies and invest in the delivery of quality patient care.

Medical Assurance Company Of Mississippi

Medical Assurance Company Of Mississippi is a Ridgeland, MS-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

DR Management

DR Management is a Fort Wayne, IN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Stemtech Healthsciences

Stemtech Healthsciences is a San Clemente, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Heron Therapeutics

Heron Therapeutics` Inc. (formerly A.P. Pharma` Inc.) is a specialty pharmaceutical company developing products using its proprietary Biochronomer™ polymer-based drug delivery platform. This drug delivery platform is designed to improve the therapeutic profile of injectable pharmaceuticals by converting them from products that must be injected once or twice per day to products that need to be injected only once every one or two weeks.